Kestra Medical Technologies, Ltd. (KMTS)

KMTS Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Year Ending	TTM	Apr 30, 2024	Apr 30, 2023
Cash & Equivalents	76.92	8.25	14.81
Cash & Cash Equivalents	76.92	8.25	14.81
Cash Growth	-	-44.30%	-
Receivables	5.39	2	-
Inventory	4.32	3.29	2.11
Other Current Assets	1.3	1.37	1.5
Total Current Assets	87.93	14.91	18.42
Property, Plant & Equipment	-	26.11	15.45
Goodwill and Intangibles	-	2.29	1.28
Other Long-Term Assets	-	2.65	3.51
Total Long-Term Assets	-	31.04	20.23
Total Assets	-	45.95	38.66
Accounts Payable	-	23.89	6.16
Current Debt	-	-	21.81
Other Current Liabilities	31.31	9.08	8.77
Total Current Liabilities	31.31	32.97	36.74
Long-Term Debt	-	45.17	17.32
Other Long-Term Liabilities	-	0.08	0.06
Total Long-Term Liabilities	-	45.25	17.39
Total Liabilities	-	78.22	54.12
Total Debt	46.1	45.17	39.13
Debt Growth	-	15.42%	-
Retained Earnings	-	-406.44	-312.32
Shareholders' Equity	-236.55	-209.38	-117.58
Net Cash / Debt	30.82	-36.92	-24.32
Working Capital	56.62	-18.06	-18.32

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).